weight loss/atrophy

This application claims benefit of Serial No. 2014-197829, filed 29 Sep. 2014 in Japan and which application is incorporated herein by reference. To the extent appropriate, a claim of priority is made to the above disclosed application. TECHNICAL FIELD The present invention relates to a cathode

This application claims priority to Japanese Patent Application No. 2011-114938, filed May 23, 2011. The above-referenced application is hereby expressly incorporated by reference in its entirety. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an adhesive

FIELD OF THE INVENTION The present invention relates to antibodies, and antigen-binding fragments thereof, which are specific for Activin A, and methods of use thereof, including methods of using antibodies specific for Activin A in conjunction with a myostatin inhibitor. BACKGROUND Activins belong

FIELD OF THE INVENTION The present invention relates to antibodies, and antigen-binding fragments thereof, which are specific for Activin A, and methods of use thereof, including methods of using antibodies specific for Activin A in conjunction with a myostatin inhibitor. BACKGROUND Activins belong

FIELD OF THE INVENTION The present invention relates to the field of medical devices, in particular electromagnetic stimulating devices for stimulation of nerve, muscle, and/or other body tissues with applications in the field of medicine. SUMMARY OF THE INVENTION The instant invention is drawn to

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents. BACKGROUND It is now accepted that the adult vertebrate brain fosters

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents. BACKGROUND It is now accepted that the adult vertebrate brain fosters

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents. BACKGROUND It is now accepted that the adult vertebrate brain fosters